Innova Captab Limited
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhib… Read more
Market Cap & Net Worth: Innova Captab Limited (INNOVACAP)
Innova Captab Limited (NSE:INNOVACAP) has a market capitalization of $467.16 Million (₹40.46 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #17127 globally and #784 in its home market, demonstrating a 3.99% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Innova Captab Limited's stock price ₹707.00 by its total outstanding shares 57224929 (57.22 Million).
Innova Captab Limited Market Cap History: 2023 to 2026
Innova Captab Limited's market capitalization history from 2023 to 2026. Data shows growth from $357.74 Million to $467.16 Million (12.81% CAGR).
Innova Captab Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Innova Captab Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Innova Captab Limited's market cap is 0.04 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.37x
Innova Captab Limited's market cap is 0.37 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $357.74 Million | $9.26 Billion | $679.54 Million | 0.04x | 0.53x |
| 2024 | $737.02 Million | $10.77 Billion | $943.45 Million | 0.07x | 0.78x |
| 2025 | $475.82 Million | $12.44 Billion | $1.28 Billion | 0.04x | 0.37x |
Competitor Companies of INNOVACAP by Market Capitalization
Companies near Innova Captab Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Innova Captab Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Innova Captab Limited Historical Marketcap From 2023 to 2026
Between 2023 and today, Innova Captab Limited's market cap moved from $357.74 Million to $ 467.16 Million, with a yearly change of 12.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹467.16 Million | -1.82% |
| 2025 | ₹475.82 Million | -35.44% |
| 2024 | ₹737.02 Million | +106.02% |
| 2023 | ₹357.74 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Innova Captab Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $467.16 Million USD |
| MoneyControl | $467.16 Million USD |
| MarketWatch | $467.16 Million USD |
| marketcap.company | $467.16 Million USD |
| Reuters | $467.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.